Pfizer, Flynn Fined £70M For Overcharging On Epilepsy Drug
Britain's competition regulator fined Pfizer Ltd. and Flynn Pharma Ltd. again Thursday after finding that they had overcharged for an epilepsy drug, imposing lower total penalties of £70 million ($84 million)...To view the full article, register now.
Already a subscriber? Click here to view full article